These observations are in line with the anti-diabetic effects found in the Smad3-KO db/db mice 25, 26, revealing Smad3 as a key transcriptional factor and therapeutic target for T2D and T2DN. Here, SMAD3 is linked to type 2 diabetes mellitus.